category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,12/138,95/8538,0.12631578947368421,7.815102974828375,8.56127349778786,3.419840342505475e-8,4.155106016144152e-6,3.617831099176845e-6,MMP1/CXCL8/IL6/CXCL1/CCL20/MMP13/MAPK13/MMP3/S100A8/PTGS2/CSF2/CXCL5,12
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,12/138,95/8538,0.12631578947368421,7.815102974828375,8.56127349778786,3.419840342505475e-8,4.155106016144152e-6,3.617831099176845e-6,MMP1/CXCL8/IL6/CXCL1/CCL20/ATP6V0D2/MMP3/HLA-DRB1/CSF2/HLA-DRB5/ICAM1/CXCL5,12
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,10/138,119/8538,0.08403361344537816,5.199123127511875,5.912271593096324,2.0880157077954867e-5,0.0016912927233143442,0.0014726005518136593,BIRC3/IL6/CXCL1/CCL20/MAPK13/MMP3/PTGS2/CSF2/ICAM1/CXCL5,10
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,9/138,103/8538,0.08737864077669903,5.406078514140988,5.766082362831074,4.018855999766677e-5,0.0024414550198582565,0.0021257633051397426,COL3A1/CXCL8/IL6/CXCL1/LAMC2/COL4A6/SERPINB3/COL4A3/CSF2,9
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,8/138,101/8538,0.07920792079207921,4.900559621179509,5.054126687635935,2.1705960202982993e-4,0.009410922054111263,0.008194045193313251,COL3A1/CXCL8/IL6/MAPK13/COL4A6/NOX4/COL4A3/ICAM1,8
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,8/138,102/8538,0.0784313725490196,4.852514919011083,5.016821747985439,2.32368445780525e-4,0.009410922054111263,0.008194045193313251,KRT17/C4A/KRT34/KRT15/HLA-DRB1/HLA-DRB5/ICAM1/PTAFR,8
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,14/138,298/8538,0.04697986577181208,2.9066238692734174,4.294000520857139,3.1400284894194286e-4,0.010900384613270302,0.009490913178545944,IL24/GDF15/CXCL8/IL6/CXCL1/ACKR3/CCL20/IL36B/INHBE/GDF6/TNFRSF8/CSF2/BMP6/CXCL5,14
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,7/138,100/8538,0.07,4.330869565217392,4.294280478051713,0.0011346854189834587,0.029454020988643987,0.02564547636438138,IL24/CXCL8/IL6/CXCL1/ACKR3/CCL20/CXCL5,7
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,7/138,100/8538,0.07,4.330869565217392,4.294280478051713,0.0011346854189834587,0.029454020988643987,0.02564547636438138,CD24/CD22/IL6/HLA-DRB1/ANPEP/CSF2/HLA-DRB5,7
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,5/138,50/8538,0.1,6.186956521739131,4.714628370446519,0.001212099629162304,0.029454020988643987,0.02564547636438138,IL6/HLA-DRB1/HLA-DRB5/PIGR/ICOS,5
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,7/138,115/8538,0.06086956521739131,3.7659735349716446,3.8275077712132815,0.0025428848276203785,0.05617463755561381,0.04891099046427714,MAOA/HTR3A/MAOB/PLA2G4B/PTGS2/KCNJ6/HTR1D,7
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,5/138,63/8538,0.07936507936507936,4.9102829537612145,3.9926491334489556,0.0034016423808141804,0.06888325821148715,0.0599763261880395,PTGES/PLA2G4B/PTGS2/CYP4F3/ALOXE3,5
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,6/138,93/8538,0.06451612903225806,3.991584852734923,3.7178812466770776,0.0038563139110930566,0.0720834061842779,0.06276267984855906,BIRC3/LAMC2/COL4A6/COL4A3/PTGS2/RXRG,6
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,9/138,196/8538,0.04591836734693878,2.8409494232475603,3.341852989223142,0.0044189921834784755,0.07670107861323354,0.06678326532926118,CXCL8/IL6/CXCL1/MAPK13/PTGS2/MAP1LC3C/CSF2/ANGPT2/ICAM1,9
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,4/138,45/8538,0.08888888888888889,5.499516908212561,3.8787708567373915,0.005827712370266275,0.09440894039831364,0.0822014165911243,IL6/HLA-DRB1/KLRD1/HLA-DRB5,4
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,6/138,105/8538,0.05714285714285714,3.5354037267080742,3.35045095212042,0.006959417032081658,0.09947872581152017,0.08661565470268814,CXCL8/BIRC3/CXCL1/PTGS2/ZAP70/ICAM1,6
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,6/138,105/8538,0.05714285714285714,3.5354037267080742,3.35045095212042,0.006959417032081658,0.09947872581152017,0.08661565470268814,COL3A1/COL17A1/COL4A6/COL4A3/PRSS3/COL8A2,6
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,6/138,109/8538,0.05504587155963303,3.405664140406861,3.2397593912168623,0.008311629149782018,0.10783419203359346,0.0938907195094316,IL6/MAPK13/HLA-DRB1/ZAP70/RXRG/HLA-DRB5,6
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,5/138,78/8538,0.0641025641025641,3.965997770345596,3.37276032856876,0.00843148003554846,0.10783419203359346,0.0938907195094316,CXCL8/IL6/C4A/MAPK13/CXCL5,5
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,8/138,182/8538,0.04395604395604396,2.7195413282369802,3.0053955396644185,0.009226696779399222,0.11210436586970055,0.09760873961364441,IL6/IRAK2/MAPK13/ATP6V0D2/HLA-DRB1/CLEC7A/LSP1/HLA-DRB5,8
Organismal Systems,Endocrine system,hsa04913,Ovarian steroidogenesis,4/138,52/8538,0.07692307692307693,4.759197324414716,3.484960194306741,0.009710128550869598,0.11236005894577678,0.09783137036214483,PLA2G4B/PTGS2/BMP6/HSD17B2,4
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,8/138,189/8538,0.042328042328042326,2.6188175753393144,2.884457359801118,0.01143111962673006,0.1262619122407002,0.1099356480848202,CXCL8/BIRC3/IL6/CXCL1/MAPK13/GBP5/MAP1LC3C/AIM2,8
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,7/138,158/8538,0.04430379746835443,2.7410566868464503,2.831209367281697,0.013991763418917143,0.14734726289025624,0.12829456288040506,CD22/LRRC4C/HLA-DRB1/CDH5/HLA-DRB5/ICAM1/ICOS,7
Human Diseases,Immune disease,hsa05310,Asthma,3/138,32/8538,0.09375,5.800271739130435,3.486829117119568,0.014552816087926542,0.14734726289025624,0.12829456288040506,HLA-DRB1/HLA-DRB5/EPX,3
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,4/138,60/8538,0.06666666666666667,4.12463768115942,3.1130143721344528,0.01584736710206863,0.1540364082321071,0.13411877000066502,MAPK13/PLA2G4B/SH2D2A/PTGS2,4
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,5/138,93/8538,0.053763440860215055,3.326320710612436,2.891104404354608,0.017148178317774654,0.1602695127392016,0.13954590452925936,MAPK13/HLA-DRB1/ZAP70/STAT4/HLA-DRB5,5
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,6/138,130/8538,0.046153846153846156,2.8555183946488296,2.7323927831724735,0.018628406661888558,0.16765565995699702,0.14597698787678753,MMP1/COL3A1/MMP13/MAPK13/COL4A6/COL4A3,6
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,4/138,66/8538,0.06060606060606061,3.749670619235837,2.8741683870325954,0.021758343373347575,0.18883133713298075,0.16441454955048357,IL6/HLA-DRB1/STAT4/HLA-DRB5,4
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,8/138,216/8538,0.037037037037037035,2.2914653784219,2.4640432632929277,0.02366274331653422,0.198277469859235,0.17263925250901557,MMP1/CXCL8/IL6/CXCL1/MAPK13/MMP3/RXRG/ICAM1,8
Metabolism,Amino acid metabolism,hsa00360,Phenylalanine metabolism,2/138,16/8538,0.125,7.733695652173913,3.455375508279418,0.026836809639912154,0.20740850248721376,0.1805895993066059,MAOA/MAOB,2
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,5/138,105/8538,0.047619047619047616,2.9461697722567286,2.5717980524197244,0.027369221083455263,0.20740850248721376,0.1805895993066059,IL6/MAPK13/PTGS2/CLEC7A/LSP1,5
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,4/138,71/8538,0.056338028169014086,3.4856093080220454,2.6955649578215453,0.027591507108345934,0.20740850248721376,0.1805895993066059,CXCL8/CXCL1/MAPK13/ATP6V0D2,4
Metabolism,Amino acid metabolism,hsa00260,"Glycine, serine and threonine metabolism",3/138,41/8538,0.07317073170731707,4.527041357370096,2.9014975772175404,0.028166586757522857,0.20740850248721376,0.1805895993066059,MAOA/MAOB/GLDC,3
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,6/138,144/8538,0.041666666666666664,2.5778985507246377,2.447532017577568,0.029044908186145243,0.20758566733039102,0.18074385589520728,CXCL8/IL6/CXCL1/C4A/MAPK13/NOX4,6
Metabolism,Amino acid metabolism,hsa00380,Tryptophan metabolism,3/138,42/8538,0.07142857142857142,4.419254658385093,2.8470912163554343,0.02998370598300578,0.20817258725344015,0.18125488428824546,KYNU/MAOA/MAOB,3
NA,NA,hsa04820,Cytoskeleton in muscle cells,8/138,232/8538,0.034482758620689655,2.1334332833583205,2.243347393875648,0.0342085482043151,0.22862694818475904,0.19906439932915992,COL3A1/BGN/LMOD1/COL4A6/SYNE3/COL4A3/MYBPC2/LDB3,8
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,5/138,112/8538,0.044642857142857144,2.7620341614906834,2.4058311786495095,0.03481151062895508,0.22862694818475904,0.19906439932915992,BIRC3/LAMC2/MAPK13/HLA-DRB1/HLA-DRB5,5
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,4/138,79/8538,0.05063291139240506,3.1326362135388,2.440750312457974,0.038699619716371036,0.24224371399781658,0.2109204527336415,MAPK13/PTGS2/HLA-DRB1/HLA-DRB5,4
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,8/138,238/8538,0.03361344537815126,2.0796492510047497,2.165133406985939,0.038878620765081674,0.24224371399781658,0.2109204527336415,F13A1/MMP1/CXCL8/IL6/C4A/MAPK13/MMP3/CSF2,8
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,6/138,157/8538,0.03821656050955414,2.3644419828302405,2.2116149683311144,0.04163357377979615,0.25292396071226164,0.22021969288786916,BIRC3/AREG/GDF6/TP73/BMP6/WNT6,6
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,3/138,50/8538,0.06,3.712173913043478,2.4652013222837708,0.04667478786026651,0.27663349878157956,0.24086347522242801,CXCL8/IL6/ICAM1,3
Metabolism,Amino acid metabolism,hsa00340,Histidine metabolism,2/138,22/8538,0.09090909090909091,5.624505928853756,2.783629276433828,0.04852069998221294,0.2807269070399463,0.24442758637656145,MAOA/MAOB,2
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,6/138,173/8538,0.03468208092485549,2.1457652676551895,1.951363929292298,0.06126781838451668,0.34030229448011245,0.29629959363440594,CXCL8/IL6/HLA-DRB1/PRSS3/HLA-DRB5/ICAM1,6
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,3/138,56/8538,0.05357142857142857,3.3144409937888195,2.2271195658442022,0.061618522457304314,0.34030229448011245,0.29629959363440594,CXCL8/IL6/CXCL1,3
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,10/138,370/8538,0.02702702702702703,1.672150411280846,1.6941895829994416,0.076360717988612,0.41234787713850485,0.3590293407183863,SPX/ADM2/KISS1/PRSS3/S1PR5/GABRG1/HTR1D/ADCYAP1R1/PAQR9/PTAFR,10
Metabolism,Lipid metabolism,hsa00561,Glycerolipid metabolism,3/138,65/8538,0.046153846153846156,2.8555183946488296,1.9246682410330884,0.08762615709482818,0.4530458760434734,0.39446489532050316,GPAT3/DGKG/PNLIPRP3,3
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,3/138,65/8538,0.046153846153846156,2.8555183946488296,1.9246682410330884,0.08762615709482818,0.4530458760434734,0.39446489532050316,KCNJ6/KISS1/CACNA1I,3
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,3/138,69/8538,0.043478260869565216,2.6899810964083173,1.8065203850503877,0.1004479544879584,0.49441180335344664,0.4304820120166462,MAPK13/PLA2G4B/CSF2,3
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,6/138,198/8538,0.030303030303030304,1.8748353096179184,1.596351093801584,0.10133709871057746,0.49441180335344664,0.4304820120166462,CXCL8/BIRC3/IL6/MMP3/CSF2/RXRG,6
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,5/138,153/8538,0.032679738562091505,2.0218812162546183,1.6347341643291284,0.10176300358443438,0.49441180335344664,0.4304820120166462,KYNU/CMPK2/NMNAT2/ALPL/NMNAT3,5
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,3/138,70/8538,0.04285714285714286,2.651552795031056,1.7782941406220976,0.10376544020998263,0.49441180335344664,0.4304820120166462,HLA-DRB1/HLA-DRB5/ICAM1,3
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,7/138,250/8538,0.028,1.7323478260869565,1.5063124676868211,0.11013826354838384,0.5101137197681729,0.44415359615942274,CXCL8/HKDC1/MAPK13/FOXO6/CYTH4/MAP1LC3C/CSF2,7
Metabolism,Xenobiotics biodegradation and metabolism,hsa00982,Drug metabolism - cytochrome P450,3/138,73/8538,0.0410958904109589,2.5425848719475876,1.69648317815353,0.11397324340378834,0.5101137197681729,0.44415359615942274,MAOA/FMO1/MAOB,3
Metabolism,Amino acid metabolism,hsa00350,Tyrosine metabolism,2/138,36/8538,0.05555555555555555,3.43719806763285,1.8781663966292876,0.11454422363055287,0.5101137197681729,0.44415359615942274,MAOA/MAOB,2
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",4/138,115/8538,0.034782608695652174,2.151984877126654,1.5940973453918628,0.11545783780761114,0.5101137197681729,0.44415359615942274,MMP13/MMP24/CYP24A1/RXRG,4
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,2/138,37/8538,0.05405405405405406,3.344300822561692,1.8316046387733123,0.11986065301878802,0.5201096193493837,0.45285697851083445,IL6/ICAM1,2
Metabolism,Metabolism of cofactors and vitamins,hsa00760,Nicotinate and nicotinamide metabolism,2/138,38/8538,0.05263157894736842,3.2562929061784898,1.786612442843123,0.12523734555759322,0.524701292594744,0.45685492662570315,NMNAT2/NMNAT3,2
Human Diseases,Immune disease,hsa05340,Primary immunodeficiency,2/138,38/8538,0.05263157894736842,3.2562929061784898,1.786612442843123,0.12523734555759322,0.524701292594744,0.45685492662570315,ZAP70/ICOS,2
Human Diseases,Immune disease,hsa05330,Allograft rejection,2/138,39/8538,0.05128205128205128,3.172798216276477,1.743092064892854,0.13067100197410678,0.538187347113694,0.46859717032641324,HLA-DRB1/HLA-DRB5,2
Organismal Systems,Immune system,hsa04660,T cell receptor signaling pathway,4/138,122/8538,0.03278688524590164,2.0285103349964366,1.4665208871885151,0.13499710032673223,0.541234108545576,0.47124997105332805,MAPK13/CSF2/ZAP70/ICOS,4
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,5/138,168/8538,0.02976190476190476,1.8413561076604552,1.4116411329017486,0.13586535235094704,0.541234108545576,0.47124997105332805,IL24/IL6/CSF2/IL22RA2/STAT4,5
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,2/138,41/8538,0.04878048780487805,3.0180275715800637,1.6601172247278952,0.14169645483788185,0.5512386170048603,0.47996084911404346,MMP1/CXCL8,2
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,3/138,81/8538,0.037037037037037035,2.2914653784219,1.4968202609243886,0.1429137155197786,0.5512386170048603,0.47996084911404346,HLA-DRB1/KLRD1/HLA-DRB5,3
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,2/138,42/8538,0.047619047619047616,2.9461697722567286,1.6205060510893783,0.14728209228062564,0.5592116941280004,0.48690296954614726,SLC7A11/MAP1LC3C,2
Metabolism,Energy metabolism,hsa00920,Sulfur metabolism,1/138,10/8538,0.1,6.186956521739131,2.1034953325249335,0.15044065143053942,0.5624165891941705,0.489693456478355,SELENBP1,1
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,2/138,44/8538,0.045454545454545456,2.812252964426878,1.544690834428493,0.15858442180845747,0.5838790075675024,0.5083806823524712,HLA-DRB1/HLA-DRB5,2
Organismal Systems,Sensory system,hsa04742,Taste transduction,3/138,86/8538,0.03488372093023256,2.1582406471183013,1.383632721996727,0.16211919413804693,0.5879845399335135,0.511955349909622,HTR3A/HCN4/HTR1D,3
Organismal Systems,Nervous system,hsa04728,Dopaminergic synapse,4/138,132/8538,0.030303030303030304,1.8748353096179184,1.2982882217141118,0.16504477851645727,0.5897923702867517,0.5135294192230327,MAOA/MAPK13/MAOB/KCNJ6,4
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,3/138,88/8538,0.03409090909090909,2.109189723320158,1.3405140174226273,0.17001125575550538,0.5947464502149715,0.5178429131176491,SERPINB2/F13A1/C4A,3
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,4/138,134/8538,0.029850746268656716,1.8468526930564568,1.2663967612027012,0.17132613792200824,0.5947464502149715,0.5178429131176491,CSF2/ZAP70/KLRD1/ICAM1,4
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,3/138,89/8538,0.033707865168539325,2.0854909623839766,1.319383659582019,0.17399875682163385,0.5955168719388313,0.5185137156582418,LAMC2/COL4A6/COL4A3,3
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,4/138,138/8538,0.028985507246376812,1.7933207309388783,1.2042072689352181,0.1841347929038144,0.6156314000351958,0.5360273398617039,CXCL8/IL6/MAPK13/ZAP70,4
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,4/138,139/8538,0.02877697841726619,1.7804191429465124,1.1889786714190982,0.18738578655961668,0.6156314000351958,0.5360273398617039,KRT17/KRT34/KRT15/KCNJ6,4
Human Diseases,Substance dependence,hsa05030,Cocaine addiction,2/138,49/8538,0.04081632653061224,2.5252883762200526,1.3723796662540626,0.18747622881730241,0.6156314000351958,0.5360273398617039,MAOA/MAOB,2
Metabolism,Amino acid metabolism,hsa00330,Arginine and proline metabolism,2/138,50/8538,0.04,2.474782608695652,1.3404877982023966,0.19334295552384567,0.6181886604249276,0.5382539343530884,MAOA/MAOB,2
Metabolism,Carbohydrate metabolism,hsa00520,Amino sugar and nucleotide sugar metabolism,2/138,50/8538,0.04,2.474782608695652,1.3404877982023966,0.19334295552384567,0.6181886604249276,0.5382539343530884,HKDC1/CYB5R2,2
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,4/138,144/8538,0.027777777777777776,1.718599033816425,1.1146433604735193,0.20391293400877747,0.6435174410926354,0.5603075835374474,MAPK13/INHBE/WNT6/ZIC3,4
Organismal Systems,Environmental adaptation,hsa04713,Circadian entrainment,3/138,97/8538,0.030927835051546393,1.9134917077543705,1.1597010951023294,0.20678040561517283,0.6442004944165,0.5609023148265821,KCNJ6/CACNA1I/ADCYAP1R1,3
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,7/138,300/8538,0.023333333333333334,1.443623188405797,1.0025741743701875,0.2117351438166541,0.6466006770473797,0.5629921424584073,MAPK13/AREG/PLA2G4B/PTPN7/ANGPT2/PGF/CACNA1I,7
Metabolism,Metabolism of cofactors and vitamins,hsa00730,Thiamine metabolism,1/138,15/8538,0.06666666666666667,4.12463768115942,1.5523927004506963,0.2170046378326228,0.6466006770473797,0.5629921424584073,ALPL,1
Human Diseases,Immune disease,hsa05320,Autoimmune thyroid disease,2/138,54/8538,0.037037037037037035,2.2914653784219,1.22020235536083,0.21702549250125616,0.6466006770473797,0.5629921424584073,HLA-DRB1/HLA-DRB5,2
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,4/138,149/8538,0.026845637583892617,1.6609279252990954,1.0431449977597642,0.22085537528778812,0.6466006770473797,0.5629921424584073,CXCL8/PLA2G4B/CYTH4/DGKG,4
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,4/138,149/8538,0.026845637583892617,1.6609279252990954,1.0431449977597642,0.22085537528778812,0.6466006770473797,0.5629921424584073,MAPK13/PTGS2/KCNJ6/GABRG1,4
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,8/138,362/8538,0.022099447513812154,1.3672832092241172,0.9152451986798054,0.23106098297225777,0.6468434277237026,0.5632035043208329,IL6/LAMC2/AREG/COL4A6/COL4A3/ANGPT2/PGF/MYB,8
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,5/138,203/8538,0.024630541871921183,1.5238809166845149,0.968234016706275,0.2312667760623599,0.6468434277237026,0.5632035043208329,BIRC3/LAMC2/COL4A6/COL4A3/PGF,5
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,3/138,103/8538,0.02912621359223301,1.8020261713803294,1.0495838752039701,0.23221900620280428,0.6468434277237026,0.5632035043208329,GPAT3/PLA2G4B/DGKG,3
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,3/138,103/8538,0.02912621359223301,1.8020261713803294,1.0495838752039701,0.23221900620280428,0.6468434277237026,0.5632035043208329,CXCL8/IL6/MAPK13,3
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,5/138,204/8538,0.024509803921568627,1.5164109121909632,0.9568333129381218,0.23424782567771948,0.6468434277237026,0.5632035043208329,IL6/MAPK13/HLA-DRB1/HLA-DRB5/ICAM1,5
Metabolism,Nucleotide metabolism,hsa00240,Pyrimidine metabolism,2/138,58/8538,0.034482758620689655,2.1334332833583205,1.1101063147726702,0.24095057089814287,0.6535557462543048,0.5690478882266202,CMPK2/UPB1,2
Metabolism,Metabolism of other amino acids,hsa00430,Taurine and hypotaurine metabolism,1/138,17/8538,0.058823529411764705,3.639386189258312,1.396158288148635,0.24215653856996278,0.6535557462543048,0.5690478882266202,FMO1,1
Metabolism,Metabolism of other amino acids,hsa00480,Glutathione metabolism,2/138,59/8538,0.03389830508474576,2.097273397199705,1.0839795253852116,0.24695489034934046,0.6535557462543048,0.5690478882266202,CHAC1/ANPEP,2
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,4/138,157/8538,0.025477707006369428,1.5762946552201607,0.9341121877607164,0.24869672041887686,0.6535557462543048,0.5690478882266202,CD24/SIRPB1/MAPK13/PTGS2,4
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,3/138,108/8538,0.027777777777777776,1.718599033816425,0.9632461020900486,0.2538353114181832,0.6535557462543048,0.5690478882266202,INHBE/GDF6/BMP6,3
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,10/138,483/8538,0.020703933747412008,1.2809433792420561,0.8147270501538159,0.2541554185780138,0.6535557462543048,0.5690478882266202,IL6/MAPK13/DKK1/NOX4/PTGS2/MAP1LC3C/DNAH3/DNAH8/WNT6/SEPTIN5,10
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,4/138,159/8538,0.025157232704402517,1.556467049494121,0.907808952003926,0.2557773691245535,0.6535557462543048,0.5690478882266202,ATP6V0D2/HLA-DRB1/CLEC7A/HLA-DRB5,4
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,3/138,109/8538,0.027522935779816515,1.7028320702034305,0.9465189930897216,0.25819486271775005,0.6535557462543048,0.5690478882266202,CXCL8/IL6/MAPK13,3
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,3/138,110/8538,0.02727272727272727,1.6873517786561265,0.9299630235349946,0.2625647726905167,0.6577653583896449,0.5727131775452399,HKDC1/IL6/ANGPT2,3
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,4/138,163/8538,0.024539877300613498,1.5182715390770871,0.8562711177589616,0.2700601427756872,0.6585558634305082,0.5734014665346856,CXCL8/IL6/MAPK13/STAT4,4
Metabolism,Lipid metabolism,hsa00140,Steroid hormone biosynthesis,2/138,63/8538,0.031746031746031744,1.9641131815044859,0.9844212565175063,0.2710106433870404,0.6585558634305082,0.5734014665346856,HSD11B1/HSD17B2,2
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,2/138,63/8538,0.031746031746031744,1.9641131815044859,0.9844212565175063,0.2710106433870404,0.6585558634305082,0.5734014665346856,GLI1/WNT6,2
Metabolism,Lipid metabolism,hsa00100,Steroid biosynthesis,1/138,20/8538,0.05,3.0934782608695657,1.2013434263062184,0.2783880892943672,0.6632186833189336,0.5774613616941983,CYP24A1,1
Metabolism,Metabolism of cofactors and vitamins,hsa00785,Lipoic acid metabolism,1/138,20/8538,0.05,3.0934782608695657,1.2013434263062184,0.2783880892943672,0.6632186833189336,0.5774613616941983,GLDC,1
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,3/138,116/8538,0.02586206896551724,1.6000749625187405,0.8340256812944307,0.28896160494258283,0.6775707188521229,0.5899576109563643,MAPK13/CDH5/ICAM1,3
Metabolism,Metabolism of cofactors and vitamins,hsa00770,Pantothenate and CoA biosynthesis,1/138,21/8538,0.047619047619047616,2.9461697722567286,1.1444572836625417,0.29007891386320694,0.6775707188521229,0.5899576109563643,UPB1,1
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,7/138,333/8538,0.021021021021021023,1.3005614309962137,0.7170816592274543,0.292777471108942,0.6775707188521229,0.5899576109563643,OASL/LAMC2/COL4A6/ATP6V0D2/COL4A3/PTGS2/WNT6,7
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,5/138,224/8538,0.022321428571428572,1.3810170807453417,0.7406550446847836,0.29585640911475036,0.6782368624045692,0.5905376189877342,IL6/HLA-DRB1/CSF2/HLA-DRB5/ICAM1,5
Metabolism,Metabolism of cofactors and vitamins,hsa00830,Retinol metabolism,2/138,68/8538,0.029411764705882353,1.819693094629156,0.8697943225095066,0.3010466012109102,0.6788799671979923,0.591097567280903,DHRS9/ALDH1A2,2
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,3/138,120/8538,0.025,1.5467391304347828,0.7730700724141677,0.3066777811247982,0.6788799671979923,0.591097567280903,IRAK2/MAPK13/TP73,3
Human Diseases,Substance dependence,hsa05031,Amphetamine addiction,2/138,69/8538,0.028985507246376812,1.7933207309388783,0.8480272799323035,0.3070346205160731,0.6788799671979923,0.591097567280903,MAOA/MAOB,2
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,4/138,174/8538,0.022988505747126436,1.422288855572214,0.721322988375486,0.3099871037303433,0.6788799671979923,0.591097567280903,APCDD1/DKK1/SFRP4/WNT6,4
Metabolism,Metabolism of terpenoids and polyketides,hsa00900,Terpenoid backbone biosynthesis,1/138,23/8538,0.043478260869565216,2.6899810964083173,1.0401739652043396,0.3128994087496919,0.6788799671979923,0.591097567280903,CHURC1-FNTB,1
Organismal Systems,Endocrine system,hsa04614,Renin-angiotensin system,1/138,23/8538,0.043478260869565216,2.6899810964083173,1.0401739652043396,0.3128994087496919,0.6788799671979923,0.591097567280903,ANPEP,1
Human Diseases,Cancer: overview,hsa05204,Chemical carcinogenesis - DNA adducts,2/138,71/8538,0.028169014084507043,1.7428046540110227,0.8055482369641623,0.31898086700509354,0.685950006037502,0.5972534165628672,HSD11B1/PTGS2,2
Metabolism,Glycan biosynthesis and metabolism,hsa00534,Glycosaminoglycan biosynthesis - heparan sulfate / heparin,1/138,24/8538,0.041666666666666664,2.5778985507246377,0.9921341898925373,0.32403503782691334,0.6866052400954722,0.5978239257491442,HS6ST3,1
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,2/138,72/8538,0.027777777777777776,1.718599033816425,0.784813176531403,0.3249366362591741,0.6866052400954722,0.5978239257491442,CXCL8/MAPK13,2
Organismal Systems,Immune system,hsa04611,Platelet activation,3/138,126/8538,0.023809523809523808,1.4730848861283643,0.6856891146715873,0.33332519449530307,0.69825881260654,0.6079706360576763,COL3A1/MAPK13/PLA2G4B,3
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,4/138,182/8538,0.02197802197802198,1.3597706641184901,0.628803234611644,0.33940018357219903,0.7049080735730289,0.6137601160414936,BIRC3/IL6/HLA-DRB1/HLA-DRB5,4
Metabolism,Lipid metabolism,hsa00592,alpha-Linolenic acid metabolism,1/138,26/8538,0.038461538461538464,2.379598662207358,0.902975926193973,0.3457716035304923,0.7118823070305799,0.6198325480318241,PLA2G4B,1
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,2/138,76/8538,0.02631578947368421,1.6281464530892449,0.7049912687665959,0.34861726146765026,0.7118823070305799,0.6198325480318241,MMP1/RXRG,2
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,3/138,133/8538,0.022556390977443608,1.3955541026479241,0.589271444059968,0.364370541670726,0.7246815216664391,0.630976763504242,IL6/MAPK13/FOXO6,3
Metabolism,Glycan biosynthesis and metabolism,hsa00601,Glycosphingolipid biosynthesis - lacto and neolacto series,1/138,28/8538,0.03571428571428571,2.2096273291925463,0.8217096113030767,0.36681410355955557,0.7246815216664391,0.630976763504242,B3GALT2,1
Metabolism,Metabolism of cofactors and vitamins,hsa00790,Folate biosynthesis,1/138,28/8538,0.03571428571428571,2.2096273291925463,0.8217096113030767,0.36681410355955557,0.7246815216664391,0.630976763504242,ALPL,1
Organismal Systems,Excretory system,hsa04966,Collecting duct acid secretion,1/138,28/8538,0.03571428571428571,2.2096273291925463,0.8217096113030767,0.36681410355955557,0.7246815216664391,0.630976763504242,ATP6V0D2,1
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,4/138,193/8538,0.02072538860103627,1.2822707817075918,0.508374725421302,0.3799849256721409,0.7300362766362825,0.6356391232570621,CXCL8/CXCL1/CCL20/CXCL5,4
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,5/138,251/8538,0.0199203187250996,1.232461458513771,0.4791171211232024,0.38247561224811366,0.7300362766362825,0.6356391232570621,CXCL8/BIRC3/IL6/MAPK13/CYTH4,5
Metabolism,Lipid metabolism,hsa00591,Linoleic acid metabolism,1/138,30/8538,0.03333333333333333,2.06231884057971,0.7470579840046638,0.38718454335044994,0.7300362766362825,0.6356391232570621,PLA2G4B,1
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,1/138,30/8538,0.03333333333333333,2.06231884057971,0.7470579840046638,0.38718454335044994,0.7300362766362825,0.6356391232570621,IL6,1
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,2/138,83/8538,0.024096385542168676,1.4908328968046098,0.5759283320295467,0.38935389029366707,0.7300362766362825,0.6356391232570621,IL6/AIM2,2
Metabolism,Metabolism of other amino acids,hsa00410,beta-Alanine metabolism,1/138,31/8538,0.03225806451612903,1.9957924263674616,0.7118917996113728,0.3971244273440604,0.7300362766362825,0.6356391232570621,UPB1,1
Metabolism,Carbohydrate metabolism,hsa00630,Glyoxylate and dicarboxylate metabolism,1/138,31/8538,0.03225806451612903,1.9957924263674616,0.7118917996113728,0.3971244273440604,0.7300362766362825,0.6356391232570621,GLDC,1
NA,NA,hsa04981,Folate transport and metabolism,1/138,31/8538,0.03225806451612903,1.9957924263674616,0.7118917996113728,0.3971244273440604,0.7300362766362825,0.6356391232570621,SLCO2B1,1
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,3/138,141/8538,0.02127659574468085,1.3163737280296022,0.48551251899228515,0.3995671802165661,0.7300362766362825,0.6356391232570621,C4A/HLA-DRB1/HLA-DRB5,3
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,3/138,141/8538,0.02127659574468085,1.3163737280296022,0.48551251899228515,0.3995671802165661,0.7300362766362825,0.6356391232570621,MAPK13/CDH5/ICAM1,3
Metabolism,Carbohydrate metabolism,hsa00052,Galactose metabolism,1/138,32/8538,0.03125,1.9334239130434783,0.6780219653159194,0.4069042356227155,0.7324276241208879,0.6377212581689343,HKDC1,1
Cellular Processes,Cell growth and death,hsa04215,Apoptosis - multiple species,1/138,32/8538,0.03125,1.9334239130434783,0.6780219653159194,0.4069042356227155,0.7324276241208879,0.6377212581689343,BIRC3,1
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,4/138,203/8538,0.019704433497536946,1.219104733347612,0.40494824165597687,0.4166925114655,0.7445314726920331,0.6482600217071633,CXCL8/IL6/MAPK13/CYTH4,4
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,2/138,89/8538,0.02247191011235955,1.3903273082559844,0.47443183798651356,0.42336787986739655,0.74988075030978385,0.6529176123554974,KCNJ6/GABRG1,2
Metabolism,Carbohydrate metabolism,hsa00051,Fructose and mannose metabolism,1/138,34/8538,0.029411764705882353,1.819693094629156,0.6138067359623137,0.42599382202888936,0.74988075030978385,0.6529176123554974,HKDC1,1
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/138,90/8538,0.022222222222222223,1.3748792270531403,0.4582349591283072,0.42894413289325084,0.74988075030978385,0.6529176123554974,MAPK13/ZAP70,2
Human Diseases,Substance dependence,hsa05032,Morphine addiction,2/138,91/8538,0.02197802197802198,1.3597706641184901,0.4422295284377829,0.43449226257966167,0.7541544271918413,0.6566386825452031,KCNJ6/GABRG1,2
Metabolism,Glycan biosynthesis and metabolism,hsa00512,Mucin type O-glycan biosynthesis,1/138,36/8538,0.027777777777777776,1.718599033816425,0.5537705678862369,0.44447329413257153,0.762373098664807,0.6637946408127624,GALNT9,1
Organismal Systems,Endocrine system,hsa04912,GnRH signaling pathway,2/138,93/8538,0.021505376344086023,1.3305282842449744,0.41077387738720017,0.445501975351451,0.762373098664807,0.6637946408127624,MAPK13/PLA2G4B,2
Metabolism,Global and overview maps,hsa01250,Biosynthesis of nucleotide sugars,1/138,37/8538,0.02702702702702703,1.672150411280846,0.5251518062046789,0.45349031194128764,0.7652649014009228,0.6663125197382954,HKDC1,1
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,1/138,37/8538,0.02702702702702703,1.672150411280846,0.5251518062046789,0.45349031194128764,0.7652649014009228,0.6663125197382954,RXRG,1
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,3/138,155/8538,0.01935483870967742,1.1974754558204768,0.3180034135321936,0.459749342074657,0.766854815890187,0.6676968507425931,PLA2G4B/PTGS2/KCNJ6,3
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,3/138,157/8538,0.01910828025477707,1.1822209914151203,0.2953607974755173,0.46815009791841045,0.766854815890187,0.6676968507425931,CXCL8/IL6/MAPK13,3
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,3/138,157/8538,0.01910828025477707,1.1822209914151203,0.2953607974755173,0.46815009791841045,0.766854815890187,0.6676968507425931,CXCL8/IL6/MAPK13,3
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,1/138,39/8538,0.02564102564102564,1.5863991081382385,0.47042915655907713,0.4710907245712661,0.766854815890187,0.6676968507425931,GLDC,1
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,3/138,159/8538,0.018867924528301886,1.1673502871205907,0.27301183224884645,0.47649362235007875,0.766854815890187,0.6676968507425931,BIRC3/PLA2G4B/STAT4,3
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,2/138,99/8538,0.020202020202020204,1.2498902064119457,0.32053383563775045,0.4778038715069335,0.766854815890187,0.6676968507425931,MAPK13/PLA2G4B,2
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,2/138,99/8538,0.020202020202020204,1.2498902064119457,0.32053383563775045,0.4778038715069335,0.766854815890187,0.6676968507425931,PLA2G4B/DGKG,2
Metabolism,Carbohydrate metabolism,hsa00500,Starch and sucrose metabolism,1/138,40/8538,0.025,1.5467391304347828,0.444226365369968,0.47967873257328575,0.766854815890187,0.6676968507425931,HKDC1,1
Human Diseases,Substance dependence,hsa05033,Nicotine addiction,1/138,41/8538,0.024390243902439025,1.5090137857900319,0.41873687223824996,0.4881282895166711,0.775262577467654,0.6750174488672233,GABRG1,1
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,4/138,226/8538,0.017699115044247787,1.0950365525202002,0.18558576735152849,0.4988949483773256,0.7821385319721943,0.6810043098393375,GLI1/HCN4/HTR1D/ADCYAP1R1,4
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,4/138,226/8538,0.017699115044247787,1.0950365525202002,0.18558576735152849,0.4988949483773256,0.7821385319721943,0.6810043098393375,CXCL8/IL6/MAPK13/PTGS2,4
Environmental Information Processing,Membrane transport,hsa02010,ABC transporters,1/138,45/8538,0.022222222222222223,1.3748792270531403,0.3231614971900597,0.5205858018311238,0.8109124990061736,0.7060576664511193,ABCA13,1
Metabolism,Glycan biosynthesis and metabolism,hsa00514,Other types of O-glycan biosynthesis,1/138,47/8538,0.02127659574468085,1.3163737280296022,0.2787548687331154,0.5360398209250126,0.8192306697155853,0.7133002582318936,GALNT9,1
Metabolism,Carbohydrate metabolism,hsa00620,Pyruvate metabolism,1/138,47/8538,0.02127659574468085,1.3163737280296022,0.2787548687331154,0.5360398209250126,0.8192306697155853,0.7133002582318936,ACOT12,1
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,1/138,47/8538,0.02127659574468085,1.3163737280296022,0.2787548687331154,0.5360398209250126,0.8192306697155853,0.7133002582318936,HKDC1,1
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,4/138,238/8538,0.01680672268907563,1.0398246255023749,0.07986448100218856,0.5398413123646756,0.8198839931538511,0.7138691038506565,PLA2G4B/ZAP70/ANGPT2/PGF,4
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,1/138,50/8538,0.02,1.237391304347826,0.2157742741210225,0.5582982769378818,0.84264895214848,0.7336904456653431,PLA2G4B,1
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,2/138,116/8538,0.017241379310344827,1.0667166416791602,0.09272740241749448,0.5628330409672464,0.8430155591877156,0.7340096486754639,HKDC1/GLDC,2
Human Diseases,Infectious disease: bacterial,hsa05110,Vibrio cholerae infection,1/138,51/8538,0.0196078431372549,1.2131287297527706,0.19566021409265927,0.5654795726238586,0.8430155591877156,0.7340096486754639,ATP6V0D2,1
Organismal Systems,Digestive system,hsa04973,Carbohydrate digestion and absorption,1/138,52/8538,0.019230769230769232,1.189799331103679,0.17595328383176834,0.5725449454267227,0.8483440349920343,0.7386491272835126,HKDC1,1
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,2/138,122/8538,0.01639344262295082,1.0142551674982183,0.020325999822432692,0.5904091739086885,0.8695116924837049,0.7570797062561173,MAPK13/S1PR5,2
Environmental Information Processing,Signal transduction,hsa04340,Hedgehog signaling pathway,1/138,56/8538,0.017857142857142856,1.1048136645962732,0.10085915511203199,0.599683923740311,0.8778505630656359,0.7643403213177078,GLI1,1
Organismal Systems,Endocrine system,hsa04923,Regulation of lipolysis in adipocytes,1/138,59/8538,0.01694915254237288,1.0486366985998525,0.04804744706207122,0.6189091055140863,0.8988290362542735,0.7826061784150271,PTGS2,1
Cellular Processes,Cell motility,hsa04814,Motor proteins,3/138,197/8538,0.015228426395939087,0.9421761200617966,-0.10524072287712531,0.6216832043069022,0.8988290362542735,0.7826061784150271,KIF26B/DNAH3/DNAH8,3
Organismal Systems,Nervous system,hsa04730,Long-term depression,1/138,60/8538,0.016666666666666666,1.031159420289855,0.031043510668316652,0.6251115519628486,0.8988290362542735,0.7826061784150271,PLA2G4B,1
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,2/138,134/8538,0.014925373134328358,0.9234263465282284,-0.11450943894399888,0.6416591031938828,0.9139129505548409,0.7957396710483995,PLA2G4B/ADM2,2
Metabolism,Amino acid metabolism,hsa00310,Lysine degradation,1/138,63/8538,0.015873015873015872,0.9820565907522429,-0.01832136912631016,0.6431239281682214,0.9139129505548409,0.7957396710483995,BBOX1,1
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,1/138,65/8538,0.015384615384615385,0.9518394648829431,-0.04995534007007294,0.6546521386696382,0.9173447551183765,0.7987277270036548,CACNA1I,1
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,2/138,139/8538,0.014388489208633094,0.8902095714732562,-0.16726713974673468,0.6614874223179716,0.9173447551183765,0.7987277270036548,MAPK13/FBXO43,2
Human Diseases,Infectious disease: viral,hsa05162,Measles,2/138,139/8538,0.014388489208633094,0.8902095714732562,-0.16726713974673468,0.6614874223179716,0.9173447551183765,0.7987277270036548,IL6/TP73,2
Metabolism,Carbohydrate metabolism,hsa00010,Glycolysis / Gluconeogenesis,1/138,67/8538,0.014925373134328358,0.9234263465282284,-0.08064955398287926,0.665810563800735,0.9173447551183765,0.7987277270036548,HKDC1,1
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,3/138,212/8538,0.014150943396226415,0.875512715340443,-0.23524871626815003,0.670979171683004,0.9173447551183765,0.7987277270036548,MAPK13/ANGPT2/PGF,3
Human Diseases,Cancer: specific types,hsa05221,Acute myeloid leukemia,1/138,68/8538,0.014705882352941176,0.909846547314578,-0.09566380614184129,0.6712548020483444,0.9173447551183765,0.7987277270036548,CSF2,1
Organismal Systems,Endocrine system,hsa04924,Renin secretion,1/138,69/8538,0.014492753623188406,0.8966603654694392,-0.11046582518578063,0.6766109811885248,0.9173447551183765,0.7987277270036548,ADCYAP1R1,1
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,2/138,143/8538,0.013986013986013986,0.8653086044390392,-0.20818530070356572,0.6767142065795873,0.9173447551183765,0.7987277270036548,SIRPB1/MAPK13,2
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,1/138,70/8538,0.014285714285714285,0.8838509316770186,-0.12506243110053863,0.6818805153243122,0.9173447551183765,0.7987277270036548,RXRG,1
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,1/138,71/8538,0.014084507042253521,0.8714023270055113,-0.13946012346452927,0.6870647960145866,0.9173447551183765,0.7987277270036548,MAPK13,1
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,1/138,71/8538,0.014084507042253521,0.8714023270055113,-0.13946012346452927,0.6870647960145866,0.9173447551183765,0.7987277270036548,HKDC1,1
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,1/138,73/8538,0.0136986301369863,0.8475282906491959,-0.16768327938505936,0.6971830527084579,0.9236305185225889,0.8042007113841907,RXRG,1
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,2/138,150/8538,0.013333333333333334,0.8249275362318841,-0.2772597345199596,0.7020266153309158,0.9236305185225889,0.8042007113841907,RXRG/WNT6,2
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,1/138,75/8538,0.013333333333333334,0.8249275362318841,-0.19518158736233548,0.7069764462765495,0.9236305185225889,0.8042007113841907,BIRC3,1
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,1/138,75/8538,0.013333333333333334,0.8249275362318841,-0.19518158736233548,0.7069764462765495,0.9236305185225889,0.8042007113841907,TP73,1
Organismal Systems,Digestive system,hsa04971,Gastric acid secretion,1/138,76/8538,0.013157894736842105,0.8140732265446224,-0.20867227900650598,0.7117545687406681,0.9249003219464298,0.8053063232022195,KCNJ16,1
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,2/138,155/8538,0.012903225806451613,0.7983169705469846,-0.32477905444552146,0.719090958722242,0.9280422495640276,0.8080419846756315,WNT6/CACNA1I,2
Metabolism,Xenobiotics biodegradation and metabolism,hsa00980,Metabolism of xenobiotics by cytochrome P450,1/138,79/8538,0.012658227848101266,0.7831590533847,-0.24816919306024304,0.7256297424574701,0.9280422495640276,0.8080419846756315,HSD11B1,1
Organismal Systems,Nervous system,hsa04721,Synaptic vesicle cycle,1/138,79/8538,0.012658227848101266,0.7831590533847,-0.24816919306024304,0.7256297424574701,0.9280422495640276,0.8080419846756315,ATP6V0D2,1
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,1/138,80/8538,0.0125,0.7733695652173914,-0.2610248927162699,0.7301058147521704,0.928878078454332,0.8087697369257991,IL6,1
Metabolism,Xenobiotics biodegradation and metabolism,hsa00983,Drug metabolism - other enzymes,1/138,81/8538,0.012345679012345678,0.7638217928073,-0.2737327160460228,0.7345093850482454,0.9296134404516856,0.8094100131288231,UPB1,1
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,1/138,85/8538,0.011764705882352941,0.7278772378516625,-0.32316285763299546,0.7514216874049008,0.9414441441682275,0.819710950737768,CMPK2,1
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,1/138,86/8538,0.011627906976744186,0.7194135490394338,-0.3351881976028737,0.7554798687769727,0.9414441441682275,0.819710950737768,AREG,1
Organismal Systems,Endocrine system,hsa04911,Insulin secretion,1/138,86/8538,0.011627906976744186,0.7194135490394338,-0.3351881976028737,0.7554798687769727,0.9414441441682275,0.819710950737768,ADCYAP1R1,1
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,1/138,87/8538,0.011494252873563218,0.711144427786107,-0.3470874143565443,0.7594722703516033,0.9415906208951,0.819838487329067,AREG,1
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,5/138,391/8538,0.01278772378516624,0.7911709107083287,-0.5417925837245355,0.7642035020680437,0.942646959403729,0.8207582362579577,IL6/DKK1/NOX4/PTGS2/WNT6,5
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,1/138,91/8538,0.01098901098901099,0.6798853320592451,-0.39348444097385743,0.7748049981808025,0.9491299754114773,0.826402967544756,CD22,1
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,1/138,93/8538,0.010752688172043012,0.6652641421224872,-0.41600296493526917,0.7821034155340012,0.9491299754114773,0.826402967544756,CDH5,1
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,1/138,98/8538,0.01020408163265306,0.6313220940550132,-0.47048032618130975,0.7993382205207848,0.9491299754114773,0.826402967544756,DGKG,1
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,1/138,98/8538,0.01020408163265306,0.6313220940550132,-0.47048032618130975,0.7993382205207848,0.9491299754114773,0.826402967544756,CACNA1I,1
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,1/138,98/8538,0.01020408163265306,0.6313220940550132,-0.47048032618130975,0.7993382205207848,0.9491299754114773,0.826402967544756,MMP3,1
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,1/138,99/8538,0.010101010101010102,0.6249451032059729,-0.4810824176355691,0.8026191832658242,0.9491299754114773,0.826402967544756,MAPK13,1
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,1/138,99/8538,0.010101010101010102,0.6249451032059729,-0.4810824176355691,0.8026191832658242,0.9491299754114773,0.826402967544756,PLA2G4B,1
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,1/138,99/8538,0.010101010101010102,0.6249451032059729,-0.4810824176355691,0.8026191832658242,0.9491299754114773,0.826402967544756,IL6,1
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,1/138,101/8538,0.009900990099009901,0.6125699526474386,-0.5020101554875115,0.8090221763025224,0.9491299754114773,0.826402967544756,WNT6,1
Human Diseases,Substance dependence,hsa05034,Alcoholism,2/138,188/8538,0.010638297872340425,0.6581868640148011,-0.6074030614738565,0.8122336668636224,0.9491299754114773,0.826402967544756,MAOA/MAOB,2
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,3/138,271/8538,0.01107011070110701,0.6849029359858815,-0.6756278978806084,0.8193804881129885,0.9491299754114773,0.826402967544756,MAOA/MAOB/SEPTIN5,3
Cellular Processes,Transport and catabolism,hsa04137,Mitophagy - animal,1/138,105/8538,0.009523809523809525,0.5892339544513457,-0.5428135463830568,0.8212159937877657,0.9491299754114773,0.826402967544756,MAP1LC3C,1
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,2/138,193/8538,0.010362694300518135,0.6411353908537959,-0.6463215782890135,0.8236769297700494,0.9491299754114773,0.826402967544756,MAPK13/CLEC7A,2
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,1/138,106/8538,0.009433962264150943,0.5836751435602954,-0.5528057039839334,0.8241416658922703,0.9491299754114773,0.826402967544756,PRSS3,1
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,1/138,109/8538,0.009174311926605505,0.5676106900678102,-0.5823079389950389,0.8326365256856971,0.9528584373250669,0.8296493216475567,IL6,1
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,1/138,111/8538,0.009009009009009009,0.5573834704269487,-0.6015963075406026,0.8380721506710136,0.9528584373250669,0.8296493216475567,MAPK13,1
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,2/138,204/8538,0.00980392156862745,0.6065643648763853,-0.7289782483218212,0.8466895392257103,0.9528584373250669,0.8296493216475567,MAPK13/WNT6,2
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,2/138,205/8538,0.00975609756097561,0.6036055143160127,-0.7363026860579478,0.8486414306065972,0.9528584373250669,0.8296493216475567,COL3A1/MAPK13,2
Organismal Systems,Nervous system,hsa04724,Glutamatergic synapse,1/138,116/8538,0.008620689655172414,0.5333583208395801,-0.6485708764594417,0.850906505759422,0.9528584373250669,0.8296493216475567,PLA2G4B,1
Organismal Systems,Nervous system,hsa04725,Cholinergic synapse,1/138,116/8538,0.008620689655172414,0.5333583208395801,-0.6485708764594417,0.850906505759422,0.9528584373250669,0.8296493216475567,KCNJ6,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,4/138,371/8538,0.01078167115902965,0.6670573069260519,-0.8403838658376072,0.8565233972381988,0.9532638136111029,0.8300022808569707,MAPK13/MAP1LC3C/DNAH3/DNAH8,4
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,1/138,122/8538,0.00819672131147541,0.5071275837491092,-0.7027714438606085,0.8649809894799932,0.9532638136111029,0.8300022808569707,RXRG,1
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",1/138,122/8538,0.00819672131147541,0.5071275837491092,-0.7027714438606085,0.8649809894799932,0.9532638136111029,0.8300022808569707,MAPK13,1
Human Diseases,Cancer: overview,hsa05207,Chemical carcinogenesis - receptor activation,2/138,215/8538,0.009302325581395349,0.575530839231547,-0.8079378721042881,0.8669600938603034,0.9532638136111029,0.8300022808569707,RXRG/NR1I3,2
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,2/138,227/8538,0.00881057268722467,0.5451063014748133,-0.8903253704330236,0.8862664066718897,0.9615948421204494,0.8372560678631594,MAPK13/NOX4,2
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,1/138,133/8538,0.007518796992481203,0.46518470088264136,-0.7967339524645519,0.8874451497568887,0.9615948421204494,0.8372560678631594,ATP6V0D2,1
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,1/138,136/8538,0.007352941176470588,0.454923273657289,-0.82127441851301,0.892899305782691,0.9615948421204494,0.8372560678631594,BIRC3,1
Metabolism,Energy metabolism,hsa00190,Oxidative phosphorylation,1/138,138/8538,0.007246376811594203,0.4483301827347196,-0.8373975090967304,0.8963888043824136,0.9615948421204494,0.8372560678631594,ATP6V0D2,1
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,1/138,138/8538,0.007246376811594203,0.4483301827347196,-0.8373975090967304,0.8963888043824136,0.9615948421204494,0.8372560678631594,HKDC1,1
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,1/138,140/8538,0.007142857142857143,0.4419254658385093,-0.8533374957092488,0.8997654071237473,0.9615948421204494,0.8372560678631594,MAP1LC3C,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,1/138,142/8538,0.007042253521126761,0.4357011635027557,-0.8690998059096174,0.9030327407274298,0.9615948421204494,0.8372560678631594,BIRC3,1
Human Diseases,Neurodegenerative disease,hsa05017,Spinocerebellar ataxia,1/138,144/8538,0.006944444444444444,0.42964975845410625,-0.884689625182554,0.9061943162369668,0.9615948421204494,0.8372560678631594,BEAN1,1
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,1/138,148/8538,0.006756756756756757,0.4180376028202115,-0.9153714066344544,0.9122136806252452,0.963773584312759,0.8391530883554887,WNT6,1
Organismal Systems,Circulatory system,hsa04261,Adrenergic signaling in cardiomyocytes,1/138,154/8538,0.006493506493506494,0.4017504234895539,-0.9602176096584182,0.9205310635013928,0.9643002012729254,0.8396116112447825,MAPK13,1
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,2/138,254/8538,0.007874015748031496,0.48716193084560083,-1.0634806944074604,0.9206487518325873,0.9643002012729254,0.8396116112447825,CACNA1I/PTAFR,2
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,1/138,158/8538,0.006329113924050633,0.39157952669235,-0.9893794706906641,0.9256363939444694,0.9653632778047471,0.8405372269385062,WNT6,1
Cellular Processes,Transport and catabolism,hsa04140,Autophagy - animal,1/138,169/8538,0.005917159763313609,0.3660921018780551,-1.0668055640044474,0.9380577205706239,0.9707705359145008,0.8452453009262062,MAP1LC3C,1
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,1/138,170/8538,0.0058823529411764705,0.36393861892583124,-1.0736560945204694,0.9390791131577017,0.9707705359145008,0.8452453009262062,WNT6,1
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,2/138,278/8538,0.007194244604316547,0.4451047857366281,-1.205579610746206,0.9428059525754,0.9707705359145008,0.8452453009262062,IL6/MAPK13,2
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,1/138,184/8538,0.005434782608695652,0.33624763705103966,-1.1665955006339412,0.9517406764463787,0.9758353771159072,0.8496552341360077,LRRC4C,1
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,2/138,311/8538,0.006430868167202572,0.3978750174751852,-1.3864321907789385,0.9639014674643025,0.9780746993317249,0.8516050013674538,DNAH3/DNAH8,2
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,2/138,312/8538,0.00641025641025641,0.3965997770345596,-1.3916850170271007,0.9644072569504099,0.9780746993317249,0.8516050013674538,CYP24A1/PTGS2,2
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,1/138,205/8538,0.004878048780487805,0.30180275715800636,-1.296901253345513,0.9659997030436789,0.9780746993317249,0.8516050013674538,ATP6V0D2,1
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,1/138,213/8538,0.004694835680751174,0.2904674423351704,-1.3440720493953453,0.9702533043394983,0.9783051989813198,0.851805696319018,MAPK13,1
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,1/138,235/8538,0.00425531914893617,0.26327474560592046,-1.4678257777756394,0.979416116694978,0.9834632907309078,0.856296822338802,MAPK13,1
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,1/138,252/8538,0.003968253968253968,0.24551414768806074,-1.558229590752669,0.9845237231435882,0.9845237231435882,0.8572201358105317,CYTH4,1
